These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38064156)
1. Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells. Ma W; Hu J Genes Genomics; 2024 Jun; 46(6):713-731. PubMed ID: 38064156 [TBL] [Abstract][Full Text] [Related]
2. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
3. Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma. Li Y; Zhu L; Hao R; Li Y; Zhao Q; Li S J Cell Mol Med; 2021 May; 25(9):4349-4362. PubMed ID: 33811453 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
6. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
7. DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma. Zuo X; Wang D; Tao C; Dou X; Zhao Z; Zhang J; Huang S; Li Y; Zhang X; Bu Y; Wang Y Front Biosci (Landmark Ed); 2024 May; 29(6):204. PubMed ID: 38940035 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma. Wang W; Li S Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484 [TBL] [Abstract][Full Text] [Related]
10. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
11. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
13. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782 [TBL] [Abstract][Full Text] [Related]
14. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
16. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
17. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target. Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539 [TBL] [Abstract][Full Text] [Related]
18. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma. Zhang X; Wu Z; Ma K BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944 [TBL] [Abstract][Full Text] [Related]
19. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells. Ren K; Yu Y; Wang X; Liu H; Zhao J Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]